UY39005A - Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting - Google Patents

Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting

Info

Publication number
UY39005A
UY39005A UY0001039005A UY39005A UY39005A UY 39005 A UY39005 A UY 39005A UY 0001039005 A UY0001039005 A UY 0001039005A UY 39005 A UY39005 A UY 39005A UY 39005 A UY39005 A UY 39005A
Authority
UY
Uruguay
Prior art keywords
sting
compositions
compounds
conditions associated
treat conditions
Prior art date
Application number
UY0001039005A
Other languages
English (en)
Spanish (es)
Inventor
Jason Katz
Hans Martin Seidel
Shankar Venkatraman
William R Roush
Original Assignee
Ifm Due Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ifm Due Inc filed Critical Ifm Due Inc
Publication of UY39005A publication Critical patent/UY39005A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
UY0001039005A 2019-12-31 2020-12-30 Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting UY39005A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962955853P 2019-12-31 2019-12-31
US202063090547P 2020-10-12 2020-10-12

Publications (1)

Publication Number Publication Date
UY39005A true UY39005A (es) 2021-07-30

Family

ID=74550729

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039005A UY39005A (es) 2019-12-31 2020-12-30 Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting

Country Status (8)

Country Link
US (1) US20230115274A1 (https=)
EP (1) EP4085061A1 (https=)
JP (1) JP2023509421A (https=)
CN (1) CN115279770A (https=)
PY (1) PY2089151A (https=)
TW (1) TW202136255A (https=)
UY (1) UY39005A (https=)
WO (1) WO2021138419A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112823036B (zh) 2018-07-03 2024-11-08 艾福姆德尤股份有限公司 用于治疗与sting活性有关的疾病的化合物和组合物
EP4267129A1 (en) 2020-12-22 2023-11-01 IFM Due, Inc. Methods of treating cancer
EP4267128A1 (en) 2020-12-22 2023-11-01 IFM Due, Inc. Methods of treating cancer
WO2022140397A1 (en) 2020-12-22 2022-06-30 Ifm Due, Inc. Methods of treating cancer
US20240060982A1 (en) 2020-12-22 2024-02-22 Ifm Due, Inc. Methods of treating cancer
JP2024502470A (ja) * 2021-01-08 2024-01-19 アイエフエム デュー インコーポレイテッド Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物
TW202235073A (zh) 2021-01-08 2022-09-16 美商Ｉｆｍ Ｄｕｅ有限公司 用於治療與sting活性相關的病狀之化合物及組合物
UY39892A (es) 2021-08-10 2023-03-31 Novartis Pharma Ag Compuestos y composiciones para tratar afecciones asociadas con la actividad de STING
WO2024032597A1 (zh) * 2022-08-11 2024-02-15 杭州中美华东制药有限公司 具有sting抑制作用的酰胺类化合物及其药物组合物和用途
WO2024064358A1 (en) 2022-09-23 2024-03-28 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
AU2023368953A1 (en) * 2022-10-28 2025-03-27 Boehringer Ingelheim International Gmbh Heterocyclic compounds as sting antagonists
CN117756698A (zh) * 2022-12-16 2024-03-26 中国药科大学 脲类化合物及其作为sting抑制剂的医药用途
CN116023321B (zh) * 2022-12-30 2024-11-29 中国药科大学 Sting抑制剂前药及其医药用途
WO2025228902A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Heterocyclic acids as sting antagonists and the use thereof as medicament
WO2025228899A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Further heterocyclic compounds as sting antagonists and the use thereof as medicament
WO2025228900A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Arylamide substituted indazoles and the use thereof as medicament
US20250333398A1 (en) 2024-04-30 2025-10-30 Boehringer Ingelheim International Gmbh Monoaryl and hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament
WO2025228895A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament
WO2025228889A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Monoarylic heterocyclic compounds as sting antagonists and the use thereof as medicament

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
WO2006083005A1 (ja) * 2005-02-03 2006-08-10 Takeda Pharmaceutical Company Limited 縮合ピリミジン誘導体およびその用途
WO2012062462A1 (en) * 2010-11-10 2012-05-18 Grünenthal GmbH Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
WO2012075380A1 (en) 2010-12-03 2012-06-07 The Trustees Of The University Of Pennsylvania Tip60 inhibitors
FR2970967B1 (fr) * 2011-01-27 2013-02-15 Pf Medicament Derives de type azaindazole ou diazaindazole comme medicament
CN109394752A (zh) 2013-10-21 2019-03-01 德雷克塞尔大学 治疗慢性乙型肝炎病毒感染的sting激动剂的用途
EP3556362A1 (en) * 2018-04-16 2019-10-23 Ecole Polytechnique Federale De Lausanne (Epfl) Sting inhibitors
CN112823036B (zh) * 2018-07-03 2024-11-08 艾福姆德尤股份有限公司 用于治疗与sting活性有关的疾病的化合物和组合物

Also Published As

Publication number Publication date
TW202136255A (zh) 2021-10-01
JP2023509421A (ja) 2023-03-08
EP4085061A1 (en) 2022-11-09
US20230115274A1 (en) 2023-04-13
WO2021138419A1 (en) 2021-07-08
CN115279770A (zh) 2022-11-01
PY2089151A (es) 2022-05-11

Similar Documents

Publication Publication Date Title
UY39005A (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting
UY38751A (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting
UY39006A (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting
UY38905A (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting
PY2201430A (es) Compuestos y composiciones para tratar condiciones asociadas con la actividad de sting
UY39328A (es) Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad del sting
CO2019008932A2 (es) Imidazo-quinolinas sustituidas como moduladores de nlrp3
EA201891565A1 (ru) Соединения и композиции для лечения состояний, ассоциированных с активностью sting
MX2018012249A (es) Moduladores de nlpr3.
CU20210094A7 (es) Inhibidores del inflamasoma nlrp3
WO2022133046A3 (en) Compounds and compositions for treating conditions associated with sting activity
UY40106A (es) Compuestos y composiciones para tratar afecciones relacionadas con la actividad de STING
ECSP24015990A (es) Compuestos y composiciones para tratar condiciones asociadas con actividad de sting
AR111693A1 (es) Compuestos de 5-metil-1,3,4-oxadiazol-2-ilo con actividad inhibitoria de oga
MX2020003868A (es) Compuesto heterociclico como inhibidor de proteina quinasa.
MY199208A (en) Benzemesulfonamide compounds and their use as therapeutic agents
ECSP20057847A (es) Moduladores de sting (estimulador de genes de interferón) a base de ciclopentano
MX2021015056A (es) Compuesto de pirrolopirimidina y uso del mismo.
TN2019000175A1 (en) Benzenesulfonamide compounds and their use as therapeutic agents
WO2022133098A3 (en) Compounds and compositions for treating conditions associated with sting activity
MX394782B (es) Compuestos para el tratamiento de enfermedades asociadas con una disfunción mitocondrial.
MX2021003904A (es) Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor apj.
EA202092719A1 (ru) Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
MX2018008157A (es) Alfa-amino esteres de derivado de hidroxipropiltiazolidin carboxamida, y formas de sales y polimorfos cristalinos de estos.
AR126753A1 (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad de sting